Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | YMAB | Common Stock | Award | $0 | +3.5K | +150% | $0.00 | 5.83K | Jun 11, 2024 | Direct | F1 |
holding | YMAB | Common Stock | 4.56M | Jun 11, 2024 | By WG Biotech ApS | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | YMAB | Employee Stock Option (right to buy) | Award | $0 | +14.5K | $0.00 | 14.5K | Jun 11, 2024 | Common Stock | 14.5K | $12.01 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Represents restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock on the vesting date of the RSUs. The RSUs vest in full on the earlier of the first anniversary of the date of grant or the date immediately preceding the date of the Issuer's annual meeting of stockholders held in 2025, subject to the Reporting Person's continued service to the Issuer on the vesting date. |
F2 | Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares. |
F3 | Stock options granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan. |
F4 | The stock options vest in equal monthly installments until the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer on each vesting date, and are exercisable immediately upon vesting. |